Triglyceride-Glucose Index in Diabetic Nephropathy in Type 2diaberes Mellitus Patients
Not yet recruiting
- Conditions
- Diabetes Mellitus, Type 2
- Registration Number
- NCT05602532
- Lead Sponsor
- Assiut University
- Brief Summary
The aim of the present study is to investigate the associations between the TyG index and diabetic nephropathy in patients with type2 DM .
- Detailed Description
the triglyceride-glucose (TyG) index was proposed as a simple and reliable surrogate marker of IR, and it has been reported to be closely correlated with the HOMA-IR index. The TyG index has the advantage of being applicable in clinical practice since both triglyceride and glucose levels are routinely measured and the cost of these measurements is low.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- patients with type 2 DM
Exclusion Criteria
- (1) Individuals with obstructive uropathy, severe heart failure, stroke, liver disease, cancer, autoimmune disease (2) Pregnant woman. (3)End stage renal disease patients on dialysis ( glomerular filtration rate <15 mL/min/1.73 m2) or renal transplantation.
(4) Type 1 Diabetic patient. (5) Albuminuria due to non-diabetic renal disease
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TyG index in type 2diaberes Mellitus Baseline Detecting the association between the TyG index and diabetic nephropathy in type 2 diabetes
- Secondary Outcome Measures
Name Time Method